-
November 24, 2021 Doug Drysdale On How CYB-003 Is Better Than PsilocybinIn this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin...
-
November 17, 2021 Interview with Sa’ad Shah, Managing Partner at Noetic FundIn our conversation, Sa’ad gives us an overview of how his interest in philosophy led...
-
November 3, 2021 Interview with Awais Spall, Functional Diagnostic Nutrition Practitioner at Integrative OasisIn this conversation, we discuss some critical points such as how he managed to heal...
-
October 22, 2021 Interview with Zoe Helene, Founder of Cosmic SisterIn our conversation, we discuss some of Zoe’s formative experiences in the creative arts which...
-
October 19, 2021 Interview with Patrick Moher, CEO of MicrodoseIn this chat, he discusses some of the challenges involved in moving virtual events to...
-
October 13, 2021 Interview with Joseph Mays, IRI Program Director at ChacrunaIn our conversation with Joseph, we chat a bit about some critical topics such as...
-
October 6, 2021 Interview with James Lanthier, CEO of Mindset PharmaIn our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when...
-
October 5, 2021 Interview with Ian McDonald, CEO & Director of Bright Minds BiosciencesIn this wide ranging interview many topics are covered, starting with the philosophy and vision...
-
September 24, 2021 Interview with Trevor Millar, Advisor, NeonMind BiosciencesIn our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based...
-
September 22, 2021 Interview with Matt Zemon, Co-Founder, PsychableIn our conversation with Matt, we tackle a variety of extremely important and highly-relevant subject...
